122 related articles for article (PubMed ID: 34092413)
21. Second malignancies in long-term testicular cancer survivors.
Ondrus D; Ondrusova M; Friedova L
Int Urol Nephrol; 2014 Apr; 46(4):749-56. PubMed ID: 24096370
[TBL] [Abstract][Full Text] [Related]
22. The risk of developing second cancers among survivors of childhood soft tissue sarcoma.
Cohen RJ; Curtis RE; Inskip PD; Fraumeni JF
Cancer; 2005 Jun; 103(11):2391-6. PubMed ID: 15852362
[TBL] [Abstract][Full Text] [Related]
23. Risk of soft tissue sarcomas by individual subtype in survivors of hereditary retinoblastoma.
Kleinerman RA; Tucker MA; Abramson DH; Seddon JM; Tarone RE; Fraumeni JF
J Natl Cancer Inst; 2007 Jan; 99(1):24-31. PubMed ID: 17202110
[TBL] [Abstract][Full Text] [Related]
24. Trends in the risk of second primary malignancies among survivors of chronic lymphocytic leukemia.
Kumar V; Ailawadhi S; Bojanini L; Mehta A; Biswas S; Sher T; Roy V; Vishnu P; Marin-Acevedo J; Alegria VR; Paulus A; Aulakh S; Iqbal M; Manochakian R; Tan W; Chanan-Khan A; Ailawadhi M
Blood Cancer J; 2019 Sep; 9(10):75. PubMed ID: 31570695
[TBL] [Abstract][Full Text] [Related]
25. Second Primary Malignancy in Bladder Carcinoma - A Population-based Study.
Khanal A; Budhathoki N; Singh VP; Shah BK
Anticancer Res; 2017 Apr; 37(4):2033-2036. PubMed ID: 28373478
[TBL] [Abstract][Full Text] [Related]
26. Secondary malignancies in long-term ovarian cancer survivors: results of the 'Carolin meets HANNA' study.
Woopen H; Rolf C; Braicu EI; Buttmann-Schweiger N; Barnes B; Baum J; Pietzner K; Kraywinkel K; Sehouli J
Int J Gynecol Cancer; 2021 May; 31(5):709-712. PubMed ID: 33649156
[TBL] [Abstract][Full Text] [Related]
27. Risk of second primary breast cancer among cancer survivors: Implications for prevention and screening practice.
Cheng Y; Huang Z; Liao Q; Yu X; Jiang H; He Y; Yao S; Nie S; Liu L
PLoS One; 2020; 15(6):e0232800. PubMed ID: 32497148
[TBL] [Abstract][Full Text] [Related]
28. A population-based study of subsequent primary malignancies after endometrial cancer: genetic, environmental, and treatment-related associations.
Brown AP; Neeley ES; Werner T; Soisson AP; Burt RW; Gaffney DK
Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):127-35. PubMed ID: 19910129
[TBL] [Abstract][Full Text] [Related]
29. Secondary Primary Malignancy Risk in Patients With Ovarian Cancer in Taiwan: A Nationwide Population-Based Study.
Hung YP; Liu CJ; Hu YW; Chen MH; Li CP; Yeh CM; Chiou TJ; Chen TJ; Yang MH; Chao Y
Medicine (Baltimore); 2015 Sep; 94(38):e1626. PubMed ID: 26402833
[TBL] [Abstract][Full Text] [Related]
30. Non-Small Cell Lung Cancer as a Second Primary Among Patients With Previous Malignancy: Who Is at Risk?
Wu GX; Nelson RA; Kim JY; Raz DJ
Clin Lung Cancer; 2017 Sep; 18(5):543-550.e3. PubMed ID: 28412093
[TBL] [Abstract][Full Text] [Related]
31. Epidemiology of Second Primary Tumors in Women With Ovarian Cancer.
Kanninen TT; Nasioudis D; Sisti G; Holcomb K; Di Tommaso M; Khalil S; Gojayev A; Witkin SS
Int J Gynecol Cancer; 2017 May; 27(4):659-667. PubMed ID: 28441249
[TBL] [Abstract][Full Text] [Related]
32. Italian cancer figures, report 2013: Multiple tumours.
AIRTUM Working Group
Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
[TBL] [Abstract][Full Text] [Related]
33. Toxicity after adjuvant therapy for stage III uterine cancer.
Chen LC; Huang Y; Hou JY; Khoury-Collado F; Melamed A; St Clair CM; Tergas AI; Hur C; Hillyer GC; Hershman DL; Wright JD
Gynecol Oncol; 2020 Dec; 159(3):737-743. PubMed ID: 33008633
[TBL] [Abstract][Full Text] [Related]
34. Childhood cancer survivors face markedly worse overall survival after diagnosis with breast cancer, melanoma, or colorectal cancer.
Lynch KT; Kane WJ; Fleming MA; Desai RP; Showalter SL; Slingluff CL; Levin DE; Hedrick TL
J Surg Oncol; 2021 Jul; 124(1):16-24. PubMed ID: 33788957
[TBL] [Abstract][Full Text] [Related]
35. Increased risk of second malignant neoplasms outside radiation fields in patients with cervical carcinoma.
Werner-Wasik M; Schmid CH; Bornstein LE; Madoc-Jones H
Cancer; 1995 May; 75(9):2281-5. PubMed ID: 7712437
[TBL] [Abstract][Full Text] [Related]
36. Risks for noncutaneous second primary malignancy in cutaneous malignant melanoma survivors: an analysis of data from the Surveillance, Epidemiology, and End Results (SEER) program.
Vakharia PP; Kelm RC; Orrell KA; Patel KR; Singam V; Ali Y; Rastogi S; Yousif R; Rangel SM; West DP; Nardone B
Int J Dermatol; 2020 Apr; 59(4):463-468. PubMed ID: 31971260
[TBL] [Abstract][Full Text] [Related]
37. Incidence of second primary malignancy after breast cancer and related risk factors-Is breast-conserving surgery safe? A nested case-control study.
Li Z; Wang K; Shi Y; Zhang X; Wen J
Int J Cancer; 2020 Jan; 146(2):352-362. PubMed ID: 30861567
[TBL] [Abstract][Full Text] [Related]
38. Second malignant neoplasms among long-term survivors of ovarian cancer.
Travis LB; Curtis RE; Boice JD; Platz CE; Hankey BF; Fraumeni JF
Cancer Res; 1996 Apr; 56(7):1564-70. PubMed ID: 8603403
[TBL] [Abstract][Full Text] [Related]
39. Second cancers among 40,576 testicular cancer patients: focus on long-term survivors.
Travis LB; Fosså SD; Schonfeld SJ; McMaster ML; Lynch CF; Storm H; Hall P; Holowaty E; Andersen A; Pukkala E; Andersson M; Kaijser M; Gospodarowicz M; Joensuu T; Cohen RJ; Boice JD; Dores GM; Gilbert ES
J Natl Cancer Inst; 2005 Sep; 97(18):1354-65. PubMed ID: 16174857
[TBL] [Abstract][Full Text] [Related]
40. Therapy-related myeloid leukemia after treatment for epithelial ovarian carcinoma: an epidemiological analysis.
Vay A; Kumar S; Seward S; Semaan A; Schiffer CA; Munkarah AR; Morris RT
Gynecol Oncol; 2011 Dec; 123(3):456-60. PubMed ID: 21855120
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
